1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pharma and Health Care Market Size Growth Rate by Format: 2016 VS 2021 VS 2027 1.2.2 Bottle 1.2.3 Blister 1.2.4 Others 1.3 Market by Application 1.3.1 Global Pharma and Health Care Market Share by Prescription: 2016 VS 2021 VS 2027 1.3.2 OTC Drugs 1.3.3 Prescription Drugs 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pharma and Health Care Market Perspective (2016-2027) 2.2 Pharma and Health Care Growth Trends by Regions 2.2.1 Pharma and Health Care Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pharma and Health Care Historic Market Share by Regions (2016-2021) 2.2.3 Pharma and Health Care Forecasted Market Size by Regions (2022-2027) 2.3 Pharma and Health Care Industry Dynamic 2.3.1 Pharma and Health Care Market Trends 2.3.2 Pharma and Health Care Market Drivers 2.3.3 Pharma and Health Care Market Challenges 2.3.4 Pharma and Health Care Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pharma and Health Care Players by Revenue 3.1.1 Global Top Pharma and Health Care Players by Revenue (2016-2021) 3.1.2 Global Pharma and Health Care Revenue Market Share by Players (2016-2021) 3.2 Global Pharma and Health Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pharma and Health Care Revenue 3.4 Global Pharma and Health Care Market Concentration Ratio 3.4.1 Global Pharma and Health Care Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pharma and Health Care Revenue in 2020 3.5 Pharma and Health Care Key Players Head office and Area Served 3.6 Key Players Pharma and Health Care Product Solution and Service 3.7 Date of Enter into Pharma and Health Care Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pharma and Health Care Breakdown Data by Format 4.1 Global Pharma and Health Care Historic Market Size by Format (2016-2021) 4.2 Global Pharma and Health Care Forecasted Market Size by Format (2022-2027) 5 Pharma and Health Care Breakdown Data by Prescription 5.1 Global Pharma and Health Care Historic Market Size by Prescription (2016-2021) 5.2 Global Pharma and Health Care Forecasted Market Size by Prescription (2022-2027) 6 North America 6.1 North America Pharma and Health Care Market Size (2016-2027) 6.2 North America Pharma and Health Care Market Size by Format 6.2.1 North America Pharma and Health Care Market Size by Format (2016-2021) 6.2.2 North America Pharma and Health Care Market Size by Format (2022-2027) 6.2.3 North America Pharma and Health Care Market Size by Format (2016-2027) 6.3 North America Pharma and Health Care Market Size by Prescription 6.3.1 North America Pharma and Health Care Market Size by Prescription (2016-2021) 6.3.2 North America Pharma and Health Care Market Size by Prescription (2022-2027) 6.3.3 North America Pharma and Health Care Market Size by Prescription (2016-2027) 6.4 North America Pharma and Health Care Market Size by Country 6.4.1 North America Pharma and Health Care Market Size by Country (2016-2021) 6.4.2 North America Pharma and Health Care Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pharma and Health Care Market Size (2016-2027) 7.2 Europe Pharma and Health Care Market Size by Format 7.2.1 Europe Pharma and Health Care Market Size by Format (2016-2021) 7.2.2 Europe Pharma and Health Care Market Size by Format (2022-2027) 7.2.3 Europe Pharma and Health Care Market Size by Format (2016-2027) 7.3 Europe Pharma and Health Care Market Size by Prescription 7.3.1 Europe Pharma and Health Care Market Size by Prescription (2016-2021) 7.3.2 Europe Pharma and Health Care Market Size by Prescription (2022-2027) 7.3.3 Europe Pharma and Health Care Market Size by Prescription (2016-2027) 7.4 Europe Pharma and Health Care Market Size by Country 7.4.1 Europe Pharma and Health Care Market Size by Country (2016-2021) 7.4.2 Europe Pharma and Health Care Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pharma and Health Care Market Size (2016-2027) 8.2 Asia-Pacific Pharma and Health Care Market Size by Format 8.2.1 Asia-Pacific Pharma and Health Care Market Size by Format (2016-2021) 8.2.2 Asia-Pacific Pharma and Health Care Market Size by Format (2022-2027) 8.2.3 Asia-Pacific Pharma and Health Care Market Size by Format (2016-2027) 8.3 Asia-Pacific Pharma and Health Care Market Size by Prescription 8.3.1 Asia-Pacific Pharma and Health Care Market Size by Prescription (2016-2021) 8.3.2 Asia-Pacific Pharma and Health Care Market Size by Prescription (2022-2027) 8.3.3 Asia-Pacific Pharma and Health Care Market Size by Prescription (2016-2027) 8.4 Asia-Pacific Pharma and Health Care Market Size by Region 8.4.1 Asia-Pacific Pharma and Health Care Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pharma and Health Care Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pharma and Health Care Market Size (2016-2027) 9.2 Latin America Pharma and Health Care Market Size by Format 9.2.1 Latin America Pharma and Health Care Market Size by Format (2016-2021) 9.2.2 Latin America Pharma and Health Care Market Size by Format (2022-2027) 9.2.3 Latin America Pharma and Health Care Market Size by Format (2016-2027) 9.3 Latin America Pharma and Health Care Market Size by Prescription 9.3.1 Latin America Pharma and Health Care Market Size by Prescription (2016-2021) 9.3.2 Latin America Pharma and Health Care Market Size by Prescription (2022-2027) 9.3.3 Latin America Pharma and Health Care Market Size by Prescription (2016-2027) 9.4 Latin America Pharma and Health Care Market Size by Country 9.4.1 Latin America Pharma and Health Care Market Size by Country (2016-2021) 9.4.2 Latin America Pharma and Health Care Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pharma and Health Care Market Size (2016-2027) 10.2 Middle East & Africa Pharma and Health Care Market Size by Format 10.2.1 Middle East & Africa Pharma and Health Care Market Size by Format (2016-2021) 10.2.2 Middle East & Africa Pharma and Health Care Market Size by Format (2022-2027) 10.2.3 Middle East & Africa Pharma and Health Care Market Size by Format (2016-2027) 10.3 Middle East & Africa Pharma and Health Care Market Size by Prescription 10.3.1 Middle East & Africa Pharma and Health Care Market Size by Prescription (2016-2021) 10.3.2 Middle East & Africa Pharma and Health Care Market Size by Prescription (2022-2027) 10.3.3 Middle East & Africa Pharma and Health Care Market Size by Prescription (2016-2027) 10.4 Middle East & Africa Pharma and Health Care Market Size by Country 10.4.1 Middle East & Africa Pharma and Health Care Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pharma and Health Care Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Johnson & Johnson 11.1.1 Johnson & Johnson Company Details 11.1.2 Johnson & Johnson Business Overview 11.1.3 Johnson & Johnson Pharma and Health Care Introduction 11.1.4 Johnson & Johnson Revenue in Pharma and Health Care Business (2016-2021) 11.1.5 Johnson & Johnson Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Pharma and Health Care Introduction 11.2.4 Novartis Revenue in Pharma and Health Care Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Roche 11.3.1 Roche Company Details 11.3.2 Roche Business Overview 11.3.3 Roche Pharma and Health Care Introduction 11.3.4 Roche Revenue in Pharma and Health Care Business (2016-2021) 11.3.5 Roche Recent Development 11.4 AbbVie 11.4.1 AbbVie Company Details 11.4.2 AbbVie Business Overview 11.4.3 AbbVie Pharma and Health Care Introduction 11.4.4 AbbVie Revenue in Pharma and Health Care Business (2016-2021) 11.4.5 AbbVie Recent Development 11.5 Merck & Co. 11.5.1 Merck & Co. Company Details 11.5.2 Merck & Co. Business Overview 11.5.3 Merck & Co. Pharma and Health Care Introduction 11.5.4 Merck & Co. Revenue in Pharma and Health Care Business (2016-2021) 11.5.5 Merck & Co. Recent Development 11.6 Bristol Myers Squibb 11.6.1 Bristol Myers Squibb Company Details 11.6.2 Bristol Myers Squibb Business Overview 11.6.3 Bristol Myers Squibb Pharma and Health Care Introduction 11.6.4 Bristol Myers Squibb Revenue in Pharma and Health Care Business (2016-2021) 11.6.5 Bristol Myers Squibb Recent Development 11.7 GlaxoSmithKline 11.7.1 GlaxoSmithKline Company Details 11.7.2 GlaxoSmithKline Business Overview 11.7.3 GlaxoSmithKline Pharma and Health Care Introduction 11.7.4 GlaxoSmithKline Revenue in Pharma and Health Care Business (2016-2021) 11.7.5 GlaxoSmithKline Recent Development 11.8 Pfizer 11.8.1 Pfizer Company Details 11.8.2 Pfizer Business Overview 11.8.3 Pfizer Pharma and Health Care Introduction 11.8.4 Pfizer Revenue in Pharma and Health Care Business (2016-2021) 11.8.5 Pfizer Recent Development 11.9 Sanofi 11.9.1 Sanofi Company Details 11.9.2 Sanofi Business Overview 11.9.3 Sanofi Pharma and Health Care Introduction 11.9.4 Sanofi Revenue in Pharma and Health Care Business (2016-2021) 11.9.5 Sanofi Recent Development 11.10 Takeda 11.10.1 Takeda Company Details 11.10.2 Takeda Business Overview 11.10.3 Takeda Pharma and Health Care Introduction 11.10.4 Takeda Revenue in Pharma and Health Care Business (2016-2021) 11.10.5 Takeda Recent Development 11.11 AstraZeneca 11.11.1 AstraZeneca Company Details 11.11.2 AstraZeneca Business Overview 11.11.3 AstraZeneca Pharma and Health Care Introduction 11.11.4 AstraZeneca Revenue in Pharma and Health Care Business (2016-2021) 11.11.5 AstraZeneca Recent Development 11.12 Bayer 11.12.1 Bayer Company Details 11.12.2 Bayer Business Overview 11.12.3 Bayer Pharma and Health Care Introduction 11.12.4 Bayer Revenue in Pharma and Health Care Business (2016-2021) 11.12.5 Bayer Recent Development 11.13 Eli Lilly & Co. 11.13.1 Eli Lilly & Co. Company Details 11.13.2 Eli Lilly & Co. Business Overview 11.13.3 Eli Lilly & Co. Pharma and Health Care Introduction 11.13.4 Eli Lilly & Co. Revenue in Pharma and Health Care Business (2016-2021) 11.13.5 Eli Lilly & Co. Recent Development 11.14 Gilead Sciences 11.14.1 Gilead Sciences Company Details 11.14.2 Gilead Sciences Business Overview 11.14.3 Gilead Sciences Pharma and Health Care Introduction 11.14.4 Gilead Sciences Revenue in Pharma and Health Care Business (2016-2021) 11.14.5 Gilead Sciences Recent Development 11.15 Amgen 11.15.1 Amgen Company Details 11.15.2 Amgen Business Overview 11.15.3 Amgen Pharma and Health Care Introduction 11.15.4 Amgen Revenue in Pharma and Health Care Business (2016-2021) 11.15.5 Amgen Recent Development 11.16 Novo Nordisk 11.16.1 Novo Nordisk Company Details 11.16.2 Novo Nordisk Business Overview 11.16.3 Novo Nordisk Pharma and Health Care Introduction 11.16.4 Novo Nordisk Revenue in Pharma and Health Care Business (2016-2021) 11.16.5 Novo Nordisk Recent Development 11.17 Teva 11.17.1 Teva Company Details 11.17.2 Teva Business Overview 11.17.3 Teva Pharma and Health Care Introduction 11.17.4 Teva Revenue in Pharma and Health Care Business (2016-2021) 11.17.5 Teva Recent Development 11.18 Boehringer Ingelheim 11.18.1 Boehringer Ingelheim Company Details 11.18.2 Boehringer Ingelheim Business Overview 11.18.3 Boehringer Ingelheim Pharma and Health Care Introduction 11.18.4 Boehringer Ingelheim Revenue in Pharma and Health Care Business (2016-2021) 11.18.5 Boehringer Ingelheim Recent Development 11.18 Biogen .1 Biogen Company Details .2 Biogen Business Overview .3 Biogen Pharma and Health Care Introduction .4 Biogen Revenue in Pharma and Health Care Business (2016-2021) .5 Biogen Recent Development 11.20 Astellas 11.20.1 Astellas Company Details 11.20.2 Astellas Business Overview 11.20.3 Astellas Pharma and Health Care Introduction 11.20.4 Astellas Revenue in Pharma and Health Care Business (2016-2021) 11.20.5 Astellas Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pharma and Health Care Market Size Growth Rate by Format (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Bottle Table 3. Key Players of Blister Table 4. Key Players of Others Table 5. Global Pharma and Health Care Market Size Growth by Prescription (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Pharma and Health Care Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Pharma and Health Care Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Pharma and Health Care Market Share by Regions (2016-2021) Table 9. Global Pharma and Health Care Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Pharma and Health Care Market Share by Regions (2022-2027) Table 11. Pharma and Health Care Market Trends Table 12. Pharma and Health Care Market Drivers Table 13. Pharma and Health Care Market Challenges Table 14. Pharma and Health Care Market Restraints Table 15. Global Pharma and Health Care Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Pharma and Health Care Market Share by Players (2016-2021) Table 17. Global Top Pharma and Health Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharma and Health Care as of 2020) Table 18. Ranking of Global Top Pharma and Health Care Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Pharma and Health Care Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Pharma and Health Care Product Solution and Service Table 22. Date of Enter into Pharma and Health Care Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Pharma and Health Care Market Size by Format (2016-2021) (US$ Million) Table 25. Global Pharma and Health Care Revenue Market Share by Format (2016-2021) Table 26. Global Pharma and Health Care Forecasted Market Size by Format (2022-2027) (US$ Million) Table 27. Global Pharma and Health Care Revenue Market Share by Format (2022-2027) & (US$ Million) Table 28. Global Pharma and Health Care Market Size Share by Prescription (2016-2021) & (US$ Million) Table 29. Global Pharma and Health Care Revenue Market Share by Prescription (2016-2021) Table 30. Global Pharma and Health Care Forecasted Market Size by Prescription (2022-2027) (US$ Million) Table 31. Global Pharma and Health Care Revenue Market Share by Prescription (2022-2027) & (US$ Million) Table 32. North America Pharma and Health Care Market Size by Format (2016-2021) (US$ Million) Table 33. North America Pharma and Health Care Market Size by Format (2022-2027) & (US$ Million) Table 34. North America Pharma and Health Care Market Size by Prescription (2016-2021) (US$ Million) Table 35. North America Pharma and Health Care Market Size by Prescription (2022-2027) & (US$ Million) Table 36. North America Pharma and Health Care Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Pharma and Health Care Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Pharma and Health Care Market Size by Format (2016-2021) (US$ Million) Table 39. Europe Pharma and Health Care Market Size by Format (2022-2027) & (US$ Million) Table 40. Europe Pharma and Health Care Market Size by Prescription (2016-2021) (US$ Million) Table 41. Europe Pharma and Health Care Market Size by Prescription (2022-2027) & (US$ Million) Table 42. Europe Pharma and Health Care Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Pharma and Health Care Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Pharma and Health Care Market Size by Format (2016-2021) (US$ Million) Table 45. Asia-Pacific Pharma and Health Care Market Size by Format (2022-2027) & (US$ Million) Table 46. Asia-Pacific Pharma and Health Care Market Size by Prescription (2016-2021) (US$ Million) Table 47. Asia-Pacific Pharma and Health Care Market Size by Prescription (2022-2027) & (US$ Million) Table 48. Asia-Pacific Pharma and Health Care Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Pharma and Health Care Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Pharma and Health Care Market Size by Format (2016-2021) (US$ Million) Table 51. Latin America Pharma and Health Care Market Size by Format (2022-2027) & (US$ Million) Table 52. Latin America Pharma and Health Care Market Size by Prescription (2016-2021) (US$ Million) Table 53. Latin America Pharma and Health Care Market Size by Prescription (2022-2027) & (US$ Million) Table 54. Latin America Pharma and Health Care Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Pharma and Health Care Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Pharma and Health Care Market Size by Format (2016-2021) (US$ Million) Table 57. Middle East & Africa Pharma and Health Care Market Size by Format (2022-2027) & (US$ Million) Table 58. Middle East & Africa Pharma and Health Care Market Size by Prescription (2016-2021) (US$ Million) Table 59. Middle East & Africa Pharma and Health Care Market Size by Prescription (2022-2027) & (US$ Million) Table 60. Middle East & Africa Pharma and Health Care Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Pharma and Health Care Market Size by Country (2022-2027) & (US$ Million) Table 62. Johnson & Johnson Company Details Table 63. Johnson & Johnson Business Overview Table 64. Johnson & Johnson Pharma and Health Care Product Table 65. Johnson & Johnson Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 66. Johnson & Johnson Recent Development Table 67. Novartis Company Details Table 68. Novartis Business Overview Table 69. Novartis Pharma and Health Care Product Table 70. Novartis Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 71. Novartis Recent Development Table 72. Roche Company Details Table 73. Roche Business Overview Table 74. Roche Pharma and Health Care Product Table 75. Roche Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 76. Roche Recent Development Table 77. AbbVie Company Details Table 78. AbbVie Business Overview Table 79. AbbVie Pharma and Health Care Product Table 80. AbbVie Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 81. AbbVie Recent Development Table 82. Merck & Co. Company Details Table 83. Merck & Co. Business Overview Table 84. Merck & Co. Pharma and Health Care Product Table 85. Merck & Co. Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 86. Merck & Co. Recent Development Table 87. Bristol Myers Squibb Company Details Table 88. Bristol Myers Squibb Business Overview Table 89. Bristol Myers Squibb Pharma and Health Care Product Table 90. Bristol Myers Squibb Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 91. Bristol Myers Squibb Recent Development Table 92. GlaxoSmithKline Company Details Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline Pharma and Health Care Product Table 95. GlaxoSmithKline Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 96. GlaxoSmithKline Recent Development Table 97. Pfizer Company Details Table 98. Pfizer Business Overview Table 99. Pfizer Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 100. Pfizer Recent Development Table 101. Sanofi Company Details Table 102. Sanofi Business Overview Table 103. Sanofi Pharma and Health Care Product Table 104. Sanofi Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 105. Sanofi Recent Development Table 106. Takeda Company Details Table 107. Takeda Business Overview Table 108. Takeda Pharma and Health Care Product Table 109. Takeda Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 110. Takeda Recent Development Table 111. AstraZeneca Company Details Table 112. AstraZeneca Business Overview Table 113. AstraZeneca Pharma and Health Care Product Table 114. AstraZeneca Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 115. AstraZeneca Recent Development Table 116. Bayer Company Details Table 117. Bayer Business Overview Table 118. Bayer Pharma and Health Care Product Table 119. Bayer Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 120. Bayer Recent Development Table 121. Eli Lilly & Co. Company Details Table 122. Eli Lilly & Co. Business Overview Table 123. Eli Lilly & Co. Pharma and Health Care Product Table 124. Eli Lilly & Co. Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 125. Eli Lilly & Co. Recent Development Table 126. Gilead Sciences Company Details Table 127. Gilead Sciences Business Overview Table 128. Gilead Sciences Pharma and Health Care Product Table 129. Gilead Sciences Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 130. Gilead Sciences Recent Development Table 131. Amgen Company Details Table 132. Amgen Business Overview Table 133. Amgen Pharma and Health Care Product Table 134. Amgen Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 135. Amgen Recent Development Table 136. Novo Nordisk Company Details Table 137. Novo Nordisk Business Overview Table 138. Novo Nordisk Pharma and Health Care Product Table 139. Novo Nordisk Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 140. Novo Nordisk Recent Development Table 141. Teva Company Details Table 142. Teva Business Overview Table 143. Teva Pharma and Health Care Product Table 144. Teva Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 145. Teva Recent Development Table 146. Boehringer Ingelheim Company Details Table 147. Boehringer Ingelheim Business Overview Table 148. Boehringer Ingelheim Pharma and Health Care Product Table 149. Boehringer Ingelheim Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 150. Boehringer Ingelheim Recent Development Table 151. Biogen Company Details Table 152. Biogen Business Overview Table 153. Biogen Pharma and Health Care Product Table 154. Biogen Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 155. Biogen Recent Development Table 156. Astellas Company Details Table 157. Astellas Business Overview Table 158. Astellas Pharma and Health Care Product Table 159. Astellas Revenue in Pharma and Health Care Business (2016-2021) & (US$ Million) Table 160. Astellas Recent Development Table 161. Research Programs/Design for This Report Table 162. Key Data Information from Secondary Sources Table 163. Key Data Information from Primary Sources List of Figures Figure 1. Global Pharma and Health Care Market Share by Format: 2020 VS 2027 Figure 2. Bottle Features Figure 3. Blister Features Figure 4. Others Features Figure 5. Global Pharma and Health Care Market Share by Prescription: 2020 VS 2027 Figure 6. OTC Drugs Case Studies Figure 7. Prescription Drugs Case Studies Figure 8. Pharma and Health Care Report Years Considered Figure 9. Global Pharma and Health Care Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Pharma and Health Care Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Pharma and Health Care Market Share by Regions: 2020 VS 2027 Figure 12. Global Pharma and Health Care Market Share by Regions (2022-2027) Figure 13. Global Pharma and Health Care Market Share by Players in 2020 Figure 14. Global Top Pharma and Health Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharma and Health Care as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Pharma and Health Care Revenue in 2020 Figure 16. Global Pharma and Health Care Revenue Market Share by Format (2016-2021) Figure 17. Global Pharma and Health Care Revenue Market Share by Format (2022-2027) Figure 18. North America Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Pharma and Health Care Market Share by Format (2016-2027) Figure 20. North America Pharma and Health Care Market Share by Prescription (2016-2027) Figure 21. North America Pharma and Health Care Market Share by Country (2016-2027) Figure 22. United States Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Pharma and Health Care Market Share by Format (2016-2027) Figure 26. Europe Pharma and Health Care Market Share by Prescription (2016-2027) Figure 27. Europe Pharma and Health Care Market Share by Country (2016-2027) Figure 28. Germany Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Pharma and Health Care Market Share by Format (2016-2027) Figure 36. Asia-Pacific Pharma and Health Care Market Share by Prescription (2016-2027) Figure 37. Asia-Pacific Pharma and Health Care Market Share by Region (2016-2027) Figure 38. China Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Pharma and Health Care Market Share by Format (2016-2027) Figure 46. Latin America Pharma and Health Care Market Share by Prescription (2016-2027) Figure 47. Latin America Pharma and Health Care Market Share by Country (2016-2027) Figure 48. Mexico Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Pharma and Health Care Market Share by Format (2016-2027) Figure 52. Middle East & Africa Pharma and Health Care Market Share by Prescription (2016-2027) Figure 53. Middle East & Africa Pharma and Health Care Market Share by Country (2016-2027) Figure 54. Turkey Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Pharma and Health Care Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Johnson & Johnson Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 58. Novartis Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 59. Roche Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 60. AbbVie Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 61. Merck & Co. Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 62. Bristol Myers Squibb Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 63. GlaxoSmithKline Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 64. Pfizer Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 65. Sanofi Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 66. Takeda Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 67. AstraZeneca Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 68. Bayer Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 69. Eli Lilly & Co. Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 70. Gilead Sciences Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 71. Amgen Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 72. Novo Nordisk Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 73. Teva Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 74. Boehringer Ingelheim Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 75. Biogen Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 76. Astellas Revenue Growth Rate in Pharma and Health Care Business (2016-2021) Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

Johnson & Johnson Novartis Roche AbbVie Merck & Co. Bristol Myers Squibb GlaxoSmithKline Pfizer Sanofi Takeda AstraZeneca Bayer Eli Lilly & Co. Gilead Sciences Amgen Novo Nordisk Teva Boehringer Ingelheim Biogen Astellas